Insider Transactions in Q1 2021 at Outlook Therapeutics, Inc. (OTLK)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 23
2021
|
Terry Dagnon Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
15,900
-1.39%
|
$31,800
$2.09 P/Share
|
|
Feb 23
2021
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,554
-0.74%
|
$17,108
$2.09 P/Share
|
|
Feb 12
2021
|
Terry Dagnon Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
63,700
-5.28%
|
$127,400
$2.55 P/Share
|
|
Feb 12
2021
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
56,973
-4.72%
|
$113,946
$2.55 P/Share
|
|
Feb 10
2021
|
Ghiath M. Sukhtian Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,013,627
+7.89%
|
$1,013,627
$1.0 P/Share
|
|
Feb 03
2021
|
Syntone Ventures LLC |
BUY
Open market or private purchase
|
Direct |
3,000,000
+13.14%
|
$3,000,000
$1.0 P/Share
|
|
Feb 02
2021
|
Ghiath M. Sukhtian Director |
BUY
Open market or private purchase
|
Indirect |
8,360,000
+43.59%
|
$8,360,000
$1.0 P/Share
|